Previous 10 | Next 10 |
Amid surge in number of new daily coronavirus cases as Delta variant spreads, Israel has approved offering a third dose of Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) COVID-19 vaccine to people of age above 40 and teachers - Reuters. The third dose will only be given to people who had rece...
The U.S. Centers for Disease Control and Prevention (CDC) has pushed back by one week a meeting set to review Covid booster shots as debate swells about the requirement of a third shot, Bloomberg reports. CDC’s independent advisory committee, the Advisory Committee for Immunization Pra...
President Joe Biden has announced that his administration will require all employees in nursing homes to get vaccinated for COVID-19, Reuters reports. “Today I’m announcing a new step,” Biden said in a speech at the White House. “If you work in a nursing home and s...
Israeli healthcare provider has said that Pfizer (PFE +2.2%) - BioNTech's (BNTX -1.7%) third COVID-19 shot was found to be 86% effective in people aged over 60, Reuters reports. Health Maintenance Organization Maccabi, compared results from 149,144 people over age of 60 who got their third do...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in a range of vaccine stocks have seen serious declines. Shares of BioNTech (NASDAQ: BNTX ), CureVac (NASDAQ: CVAC ) and Novavax (NASDAQ: NVAX ) all saw marked declines this morning. ...
CureVac Announces Financial Results for the Second Quarter and First Half of 2021 and Provides Business Update Continuation of corporate transformation into commercial-ready biopharma company Management team strengthened with appointments of Chief Operating Officer Malte Greune and Chi...
With COVID-19 expected to become an endemic virus, the analysts project leading vaccine makers such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) to reap billions from COVID-19 booster shots until competitors arrive. Speaking to CNBC on Friday, Dr. Scott Gottlieb a former FDA commissioner sa...
The U.S. Centers for Disease Control and Prevention (CDC) said that pregnant individuals should be vaccinated against COVID-19, based on a new analysis that did not show increased risk for miscarriage. Pregnant women can receive any of the three vaccines given U.S. emergency authorization - P...
According to a large U.S. study published in The Lancet Regional Health, individuals who contract COVID-19 while pregnant face a higher risk of having preterm birth - The IndianExpress reports. The preterm birth rate with a COVID-19 diagnosis was 11.8% compared with 8.7% among those without t...
The short-term thesis for investing in Moderna is the belief that the company will continue to profit from its COVID-19 vaccine because of booster shots. The long-term thesis for investing in Moderna is the belief that the company has more success to come from a promising vaccine...
News, Short Squeeze, Breakout and More Instantly...
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent ...
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinations CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone pa...
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation to create leaner and more agile organization Prioritization of high-value opportunities in oncology and other selected diseases, leveraging proprietary mRNA tec...